New YorkRelates to prescription labels for mifepristone and misoprostol
What it does
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Mar 20SIGNED CHAP.108Became Law
- Mar 20DELIVERED TO GOVERNORTo Governor
- Mar 10RETURNED TO ASSEMBLY
- Vote recorded Floor Vote. Result: pass.Upper
- Mar 10PASSED SENATEPassed 2nd Chamber
- Mar 103RD READING CAL.447
- Mar 10SUBSTITUTED FOR S4587
- Mar 5REFERRED TO RULESMinor
- Vote recorded Assembly Vote. Result: pass.Lower
- Mar 5DELIVERED TO SENATE
- Mar 5PASSED ASSEMBLYPassed 1st Chamber
- Feb 25ORDERED TO THIRD READING RULES CAL.103
- Feb 25RULES REPORT CAL.103
- Feb 25REPORTED
- Feb 24REPORTED REFERRED TO RULESMinor
- Feb 12REFERRED TO HIGHER EDUCATIONIntroduced